Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Peak Bio, Inc.PKBO · Entity 85431 | Director | November 01, 2022 | November 04, 2022 |
| Rezolute, Inc.RZLT · Entity 1990 | Director · CEO | July 02, 2026 | July 07, 2026 |
| Savara IncSVRA · Entity 4900 | Director | December 09, 2025 | December 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Peak Bio, Inc.
Report date November 01, 2022 · Filed November 04, 2022
This filing explicitly reported no securities owned.
Rezolute, Inc.
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 605,497 |
Reported balance
After 2026-07-02 transaction · row 1
1 source rowRow 1 · 2026-07-02 · Tax withholding · Disposed 8,004 · Balance 605,497 F1: The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Savara Inc
Report date December 09, 2025 · Filed December 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 106,887 |
Reported balance
After 2025-12-09 transaction · row 1
1 source rowRow 1 · 2025-12-09 · Grant · Acquired 40,000 · Balance 106,887 F1: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 04, 2019 Filed Feb 5, 2019 22:36 UTC | Savara Inc SVRA · Entity 4900 | Exercise / conversionCommon Stock | 21,682 | $0.19 | $4,119.58 |
DisclosureSEC source: 0000899243-19-002657 · doc4.xml · nonDerivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:41 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $7.33 | $0.00 |
DisclosureSEC source: 0000899243-18-031102 · doc4.xml · derivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-12-13 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 13, 2018, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 17, 2017 Filed Dec 20, 2017 00:02 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $15.21 | $0.00 |
DisclosureSEC source: 0000899243-17-029246 · doc4.xml · derivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2027-12-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer. Read SEC document |
| October 31, 2016 Filed Jan 14, 2017 00:30 UTC | Rezolute, Inc. ANTB · Entity 1990 | GrantStock Option (right to buy) · Derivative | 3,500,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001140361-17-001943 · doc1.xml · derivative · entry 1 Elam Nevan C · CIK 0001314773 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500,000 Underlying: Common Stock · 3,500,000 shares Expires 2026-10-31 F1 · shares: On October 31, 2016, the Reporting Person was granted 9,500,000 shares of common stock. Pursuant to Board approval and a Refresh Option Agreement, the number of shares was reduced for no consideration on December 27, 2016. An additional 3,600,000 shares may be issued upon certain performance only criteria. F2 · derivative.exercise_date: The option vests in forty-eight equal installments beginning on the date so indicated and every month thereafter, such grant vested in full at 4 years. F1 · derivative.underlying_shares: On October 31, 2016, the Reporting Person was granted 9,500,000 shares of common stock. Pursuant to Board approval and a Refresh Option Agreement, the number of shares was reduced for no consideration on December 27, 2016. An additional 3,600,000 shares may be issued upon certain performance only criteria. F1 · balance_after: On October 31, 2016, the Reporting Person was granted 9,500,000 shares of common stock. Pursuant to Board approval and a Refresh Option Agreement, the number of shares was reduced for no consideration on December 27, 2016. An additional 3,600,000 shares may be issued upon certain performance only criteria. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.